Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF) Meeting Abstract


Authors: Kramer, K.; Modak, S.; Kushner, B. H.; Souweidane, M.; Wolden, S.; Humm, J.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N.
Abstract Title: Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF)
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 80s
Language: English
ACCESSION: WOS:000455043700331
PROVIDER: wos
Notes: Meeting Abstract: 2022 -- Source: Wos